Press Release
Bolt Biotherapeutics Prices Upsized Initial Public Offering
This author has yet to write their bio.
Meanwhile lets just say that we are proud Andrea Tu contributed a whooping 52 entries.
Bolt Biotherapeutics Prices Upsized Initial Public Offering
Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte
Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting
Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform
Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting
Bolt Biotherapeutics Closes $93.5 Million Series C Financing
Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs Xconomy
You acknowledge that the personal information you provide to Bolt Biotherapeutics will be processed to respond to your request or inquiry. For more information, please review our Privacy Notice .